These data support our hypothesis and demonstrate that phosphorylation events contribute to both expression of the SUMO-deficient PR gene signature and PR-induced proliferation in otherwise unmodified (that is, containing WT PRs) SR-positive breast cancer cells. This evidence concerns the gene WNK3 and breast carcinoma.